Skip to content

An Observational Study On The Relationship Of Psoriasis With Liver And Spleen

AN OBSERVATIONAL STUDY ON SIDMA KUSHTA IN RELATION TO YAKRIT AND PLIHA AS MOOLA STHANA OF RAKTAVAHA SROTAS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/12/048399
Enrollment
42
Registered
2022-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

None listed

Sponsors

PARUL INSTITUTE OF AYURVEDA
Lead Sponsor
GOVT AYURVEDA COLLEGE TRIPUNITHURA
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: DIAGNOSED OF PSORIASIS FULFILLING THE CRITERIA OF SIDMAKUSHTA

Exclusion criteria

Exclusion criteria: PEOPLE WHO HAVE BEEN DIAGNOSED OF CHRONIC LIVER DISEASE PREGNANT AND LACTATING WOMEN PEOPLE WHO ARE NOT WILLING TO GIVE THE INFORMED CONSENT

Design outcomes

Primary

MeasureTime frame
To study the relation between Sidmakushta and the structural aberration and dysfunction of the yakrit (liver) and pliha (spleen) as moola sthana of raktavaha srotas.Timepoint: At Baseline

Secondary

MeasureTime frame
1.To Study The Relation Between Sidma Kushta and Structural Aberration Of Liver. 2.To Study The Relation Between Sidma Kushta And Structural Aberration of Spleen. 3.To Study The Relation Between Sidma Kushta And Biochemical Markers Related To Liver. 4. To Study The Relation Between Sidma Kushta And The Structural Aberration And Dysfunction Of The Yakrit (Liver) And Pliha (Spleen) As Moolasthanas Of Raktavaha Srotas In An Animal Model. Timepoint: 1.In Patients At Baseline 2.In Animal Model It Will Be Observed Seven Days After Inducing Psoriasis

Countries

India

Contacts

Public ContactDr VIJAYNATH V

Parul Institute Of Ayurveda

dattabandapalle5@gmail.com9881833437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026